Literature DB >> 28299745

Matrix Metalloproteases as Biomarkers of Disease.

Fernando Luiz Affonso Fonseca1,2, Beatriz da Costa Aguiar Alves3, Ligia Ajaime Azzalis4, Thaís Moura Gáscon Belardo3.   

Abstract

Matrix metalloprotease play a vital role in many cellular processes. Dysfunction in activity of these enzymes has been implicated in the pathogenesis of a number of diseases. Factors that affect the balanced interaction between MMPs and their inhibitors, such as genetic mutations of extracellular matrix components or dysregulation of MMP expression, can lead to various diseases. Due to their essential role in ECM remodeling, MMPs have become targets of interest as biomarkers for the diagnosis and prognosis of diseases associated with alterations of the ECM.

Entities:  

Keywords:  Cancer; Disease; Inflammatory disease; Matrix metalloproteases

Mesh:

Substances:

Year:  2017        PMID: 28299745     DOI: 10.1007/978-1-4939-6863-3_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells.

Authors:  Pei Zhang; Jie Ma; Jiao Gao; Fang Liu; Xiaojin Sun; Fang Fang; Surong Zhao; Hao Liu
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

Review 2.  Diagnosis and Prognosis of Prostate Cancer from Circulating Matrix Metalloproteinases and Inhibitors.

Authors:  William Khalil El-Chaer; Clayton Franco Moraes; Otávio Toledo Nóbrega
Journal:  J Aging Res       Date:  2018-07-10

3.  Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.

Authors:  Weiwei Chen; Shenjiao Huang; Kun Shi; Lisha Yi; Yaqiong Liu; Wenjie Liu
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

4.  Transcriptome analysis of Klf15‑mediated inhibitory functions in a mouse deep venous thrombosis model.

Authors:  Jin Zhou; Xueling Zhao; Shiwei Xie; Rudan Zhou
Journal:  Int J Mol Med       Date:  2020-03-13       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.